Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 576-589

  Sancho, Elena ^a   Vilá, Maya R ^a,h   Sánchez Pulido, Luis ^b   Lozano, Juan José ^c   Paciucci, Rosanna ^a   Nadal, Marga ^d   Fox, Margaret ^e   Harvey, Clare ^a,e   Bercovich, Brenda ^f   Loukili, Nourredine ^a   Ciechanover, Aaron ^f   Lin, Stanley L ^g   Sanz, Ferran ^c   Estivill, Xavier ^d   Valencia, Alfonso ^b   Thomson, Timothy M ^a  

^a CSIC   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d Institut de Recerca Oncologica   (Spain)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN CONJUGATING ENZYME;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SECRETORY CELL;

MAMMALIA;

EID: 0031962188     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.1.576     Document Type: Article

References (73)

1. Arion, D., L. Meijer, L. Brizuela, and U. Beach. 1988. cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF. Cell 55:171-378.
2. Bailly, V., J. Lamb, P. Sung, S. Prakash, and L. Prakash. 1994. Specific complex formation between yeast RAD6 and RAD18 proteins: a potential mechanism for targeting RAD6 ubiquitin-conjugating activity to DNA damage sites. Genes Dev. 8:811-820.
3. Banerjee A., R. J. Deshaies, and V. Chau. 1995. Characterization of a dominant negative mutant of the cell cycle ubiquitin-conjugating enzyme Cdc34. J. Biol. Chem. 270:26209-26215.
4. Barila, D., C. Murgia, F. Nobili, S. Gaetani, and G. Perozzi. 1994. Subtractive hybridization cloning of novel genes differentially expressed during intestinal development. Eur. J. Biochem. 223:701-709.
5. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:2324-2331.
6. Broek, D., R. Bartlett, K. Crawford, and P. Nurse. 1991. Involvement of p34cdc2 in establishing the dependency of S phase in mitosis. Nature 349: 388-393.
7. Chen, P., P. Johnson, T. Sommer, S. Jentsch, and M. Hochstrasser. 1993. Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MATα2 repressor. Cell 74:357-369.
8. Chen, X., L. J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response to tumor cells. Genes Dev. 10:2438-2451.
9. Chomczynsky, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:12-21.
11. Cook, W. J., L. C. Jeffrey, M. L. Sullivan, and R. D. Vierstra. 1992. Three-dimensional structure of a ubiquitin-conjugating enzyme (E2). J. Biol. Chem. 267:15116-15121.
12. Cook, W. J., L. C. Jeffrey, Y. Xu, and V. Chau. 1993. Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4. Biochemistry 32:13809-13817.
13. Cook, W. J., P. D. Martin, B. F. Edwards, R. K. Yamazaki, and V. Chau. 1997. Crystal structure of a class I ubiquitin conjugating enzyme (Ubc7) from Saccharomyces cerevisiae at 2.9 angstroms resolution. Biochemistry 36:1621-1627.
14. Diaz-Meco, M., I. Dominguez, L. Sanz, M. M. Municio, E. Berra, M. E. Cornet, A. Garcia de Herreros, T. Johansen, and J. Moscat. 1992. Phospholipase C-mediated hydrolysis of phosphatidylcholine is a target of transforming growth factor-β1 inhibitory signals. Mol. Cell. Biol. 12:302-308.
15. Fabre, M., and A. Garcia de Herreros. 1993. Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin. J. Cell Sci. 106(Part 2):513-521.
16. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
17. Felix, M.-A., P. Cohen, and E. Karsenti. 1990. Cdc2 H1 kinase is negatively regulated by a type 2A phosphatase in the Xenopus early embryonic cell cycle: evidence from the effects of okadaic acid. EMBO J. 9:675-683.
18. Gonen, H., I. Stancovski, D. Shkedy, T. Hadari, B. Bercovich, E. Bengal, S. Mesilati, O. Abu-Hatoum, A. L. Schwartz, and A. Ciechanover. 1996. Isolation characterization, and partial purification of a novel ubiquitin-protein ligase, E3. J. Biol. Chem. 271:302-310.
19. Gordon, J. I., and M. L. Hermiston. 1994. Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr. Opin. Cell Biol. 6:795-803.
20. Gosink, M. M., and R. D. Vierstra. 1995. Redirecting the specificity of ubiquitination by modifying ubiquitin-conjugating enzymes. Proc. Natl. Acad Sci. USA 92:9117-9121.
21. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
22. Hayles, J., D. Fisher, A. Woollard, and P. Nurse. 1994. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex. Cell 78:813-822.
23. cdc2. J. Virol. 69:6705-6711.
24. Huet, C., C. Sahuquillo-Merino, E. Coudrier, and D. Louvard. 1987. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J. Cell Biol. 105:345-357.
25. Jentsch, S. 1992. The ubiquitin-conjugation system. Annu. Rev. Genet. 26: 179-207.
26. 2-M phase of the cell cycle. J. Virol. 69:6304-6313.
27. Kaiser, P., S. Mandl, M. Schwiger, and R. Schneider. 1995. Characterization of functionally independent domains in the human ubiquitin conjugating enzyme UbcH2. FEBS Lett. 377:193-196.
28. Kitamura, H., M. Cho, B. H. Lee, J. R. Gum, B. B. Siddiki, S. B. Ho, N. W. Toribara, T. Lesuffleur, A. Zweibaum, S. Kitamura, and Y. S. Kim. 1996. Alteration in mucin gene expression and biological properties of HT-29 colon cancer cell subpopulations. Eur. J. Cancer 32A:1788-1796.
29. cdc2 kinase activation in vertebrates. EMBO J. 10:3331-3341.
30. Koonin, E. V., and R. A. Abagyan. 1997. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16:330-331.
31. Lee, M. P., and A. P. Feinberg. 1997. Aberrant splicing but not mutations of TSG101 in human breast cancer. Cancer Res. 57:3131-3134.
32. Lesuffleur, T., A. Barbat, C. Luccioni, J. Beaumetin, M. Clair, A. Kornowski, E. Dussaulx, B. Dutrillaux, and A. Zweibaum. 1991. Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells. J. Cell Biol. 115:1409-1418.
33. Lesuffleur, T., N. Porchet, J.-P. Aubert, D. Swallow, J. R. Gum, Y. S. Kim, F. X. Real, and A. Zweibaum. 1993. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J. Cell Sci. 106:771-783.
34. Li, L., and S. N. Cohen. 1996. tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85:319-329.
35. Li, L., X. Li, U. Francke, and S. N. Cohen. 1997. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-154.
36. Louvard, D., M. Kedinger, and H. P. Hauri. 1992. The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures. Annu. Rev. Cell Biol. 8:157-195.
37. Madura, K., R. J. Dohmen, and A. Varshavsky. 1993. N-recognin/Ubc2 interactions in the N-end rule pathway. J. Biol. Chem. 268:12046-12054.
38. Matuschewski, K., H. P. Hauser, M. Treier, and S. Jentsch. 1996. Identification of a novel family of ubiquitin-conjugating enzymes with distinct amino-terminal extensions. J. Biol. Chem. 271:2789-2794.
39. Moreno, S., and P. Nurse. 1994. Regulation of progression through the G1 phase of the cell cycle by the rum1+ gene. Nature 367:236-242.
40. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
41. Murray, A. 1995. Cyclin ubiquitination: the destructive end of mitosis. Cell 81:149-152.
42. Nadal, M., M. Mila, M. Pritchard, A. Mur, J. Pujals, J. L. Blouin, S. E. Antonarakis, F. Ballesta, and X. Extivill. 1996. YAC and cosmid FISH mapping of an unbalanced chromosomal translation causing partial trisomy 21 and Down syndrome. Hum. Genet. 9:460-466.
43. Nagai, Y., S. Kaneda, K. Nomura, H. Yasuda, T. Seno, and F. Yamao. 1995. Ubiquitin-activating enzyme, E1, is phosphorylated in mammalian cells by the protein kinase Cdc2. J. Cell Sci. 108:2145-2152.
44. Neutra, M., and D. Louvard. 1989. Differentiation of intestinal cells in vitro, p. 363-398. In K. S. Matlin and J. D. Valentich (ed.), Functional epithelial cells in culture. Alan R. Liss, Inc., New York, N.Y.
45. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
46. Perucho, M., J. Welsh, M. A. Peinado, Y. Ionov, and M. McClelland. 1995. Fingerprinting of DNA and RNA by arbitrarily primed polymerase chain reaction: applications in cancer research. Methods Enzymol. 254:275-290.
47. Pinto, M., M. D. Appay, P. Simon-Assman, G. Chevalier, N. Dracopoli, J. Fogh and A. Zweibaum. 1982. Enterocytic differentiation of cultured human colon cancer cells by replacement of glucose by galactose in the medium. Biol. Cell. 44:193-196.
48. Pitluk, Z. W., M. McDonough, P. Sangan, and D. K. Gonda. 1995. Novel CDC34 (UBC3) ubiquitin-conjugating enzyme mutants obtained by charge-to-alanine scanning mutagenesis. Mol. Cell. Biol. 15:1210-1219.
49. Ponting, C. P., Y.-D. Cai, and P. Bork. 1997. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. 75:467-469.
50. Ptak, C., J. A. Prendergast, R. Hodgins, C. M. Kay, V. Chau, and M. J. Ellison. 1994. Functional and physical characterization of the cell cycle ubiquitin-conjugating enzyme CDC34 (UBC3). Identification of a functional determinant within the tail that facilitates CDC34 self-association. J. Biol. Chem. 269:26539-26545.
51. Rehli, F. J., S. W. Krause, R. Andreseen, and M. Kreutz. 1997. Molecular cloning of a 1α,25-dihydroxyvitamin D3-inducible transcript (DDVit 1) in human blood monocytes. Biochem. Biophys. Res. Commun. 234:407-412.
52. Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888.
53. Rost, B., and C. Sander. 1993. Prediction of protein secondary structure better than 70% accuracy. J. Mol. Biol. 232:584-599.
54. Rothofsky, M. L., and S. L. Lin. 1997. CROC-1 encodes a protein which mediates transcriptional activation from the human FOS promoter. Gene 195:141-149.
55. Russell, K. J., L. W. Wiens, G. W. Demers, D. A. Galloway, S. E. Plon, and M. Groudine. 1995. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 55:1639-1642.
56. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
57. Scarano, F. J., J. A. Laffin, J. M. Lenman, and T. D. Friedrich. 1994. Simian virus 40 prevents activation of M-phase-promoting factor during lytic infection. J. Virol. 68:2355-2361.
58. Schuler, G. D., M. S. Boguski, E. A. Stewart, L. D. Stein, G. Gyapay, et al. 1996. A gene map of the human genome. Science 274:540-546.
59. Simon, T. C., and J. I. Gordon. 1995. Intestinal epithelial cell differentiation: new insights from mice, flies and nematodes. Curr. Opin. Genet. Dev. 5: 577-586.
60. Siyanova, E. Y., M. S. Serfas, I. A. Mazo, and A. L. Tyner. 1994. Tyrosine kinase gene expression in the mouse small intestine. Oncogene 9:2053-2057.
61. Stein, G. S., J.L. Stein, J. B. Lian, T. J. Last, T. OWen, and L. McCabe. 1994. Synchronization of normal dipoid and transformed mammalian cells, p. 282-287. In J. E. Celis (ed.), Cell biology. A laboratory handbook. Academic Press, Inc., London, England.
62. Suh, E., and P. G. Traber. 1996. An intestine-specific homeohox gene regulates proliferation and differentiation. Mol. Cell. Biol. 16:619-625.
63. Sung, P., S. Prakash, and L. Prakash. 1990. Mutation of cysteine-88 in the Saccharomyces cerevisiae RAD6 protein abolishes its ubiquitin-conjugating activity and its various biological functions. Proc. Natl. Acad. Sci. USA 87:2695-2699.
64. Sykes, D. E., and M. M. Weiser. 1992. The identification of genes specifically expressed in epithelial cells of the rat intestinal crypts. Differentiation 50: 41-46.
65. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
66. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:43511-4354.
67. Usui, T., M. Yoshida, K. Abe, H. Osada, K. Isono, and T. Beppu. 1991. Uncoupled cell cycle without mitosis induced hy a protein kinase inhibitor. K-252a. J. Cell Biol. 115:1275-1282.
68. Vasioukhin, V., M. S. Servas, E. Y. Siyanova, M. Polonskaia, V. J. Costigan, B. Liu, A. Thomason, and A. L. Tyner. 1995. A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract. Oncogene 10:349-357.
69. Vilá, M. R., J. Lloreta, M. H. Schüssler, G. Berrozpe, S. Welt, and F. X. Real. 1995. New pancreas cancer cell lines which represent distinct stages of ductal differentiation. Lab. Invest. 72:395-404.
70. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:52-56.
71. Waldman, T., C. Lengauer, K. W. Kinzler, and B. Vogelstein. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381:713-716.
72. Welsh, J., K. Chada, S. S. Dalal, R. Cheng, D. Ralph, and M. McClelland. 1992. Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res. 20:4965-4970.
73. Zweibaum, A., M. Laburthe, E. Grasset, and D. Louvard. 1991. Use of cultured cell lines in studies of intestinal cell differentiation and function, p. 223-255. In M. Field and R. A. Frizzel, (ed.), Handbook of physiology. The gastrointestinal system, vol. IV. Intestinal absorption and secretion. American Physiological Society, Bethesda, Md.